Showing results (1381-1390 of 1,955) with videos related to
Sort By:
Pageof 196
Blood|October 30, 2010
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencingAndrew L Feldman, Ahmet Dogan, David I Smith, et al.Blood|July 20, 2016
Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphomaRobert Chen, Ajay K Gopal, Scott E Smith, et al.Molecular Cancer Research : MCR|November 18, 2008
Period 2 mutation accelerates ApcMin/+ tumorigenesisPatricia A Wood, Xiaoming Yang, Andrew Taber, et al.Plos One|September 22, 2015
Systematic Review and Meta-Regression of Factors Affecting Midline Incisional Hernia Rates: Analysis of 14,618 PatientsDavid C Bosanquet, James Ansell, Tarig Abdelrahman, et al.Plos Neglected Tropical Diseases|December 5, 2015
Time-Dependent Transcriptional Changes in Axenic Giardia duodenalis TrophozoitesBrendan R E Ansell, Malcolm J McConville, Louise Baker, et al.Haematologica|June 19, 2025
Treatment approaches and clinical outcomes in primary colorectal MALT lymphoma: a single institution retrospective study of 66 patientsSuheil Albert Atallah-Yunes, Matthew J Rees, Thomas M Habermann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancerCharles M Rudin, Ann Mauer, Martin Smakal, et al.The Lancet. Oncology|March 29, 2011
Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 studyStephen M Ansell, Hui Tang, Paul J Kurtin, et al.American Heart Journal|December 16, 2014
Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialChristopher B Granger, Renato D Lopes, Michael Hanna, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 29, 2005
Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantationVianda S Stel, Paul C W van Dijk, Jeannette G van Manen, et al.Pageof 196